Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000919574-99-000493
Filing Date
1999-03-01
Accepted
1999-03-01 00:00:00
Documents
1
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 3 2918
  Complete submission text file 0000919574-99-000493.txt   4867
Mailing Address CURRAN PARTNERS LP 230 PARK AVENUE NEW YORK NY 1010017
Business Address CURRAN PARTNERS LP 230 PARK AVENUE NEW YORK NY 10017 2128082400
CURRAN JOHN P (Reporting) CIK: 0000026256 (see all company filings)

 

Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 225 EAST DEERPATH STE 250 LAKE FOREST IL 60045 7082958678
NEOPHARM INC (Subject) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-12493 | Film No.: 99554261
SIC: 8731 Services-Commercial Physical & Biological Research